MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

499790

Report Date :

29.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

TEVA PHARMACEUTICAL AND CHEMICAL INDUSTRIES INDIA PRIVATE LIMITED

 

 

Registered Office :

M-34 Saket, New Delhi - 110017

Tel. No.:

91-120-4073275

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

02.05.2003

 

 

Com. Reg. No.:

55-183289

 

 

Capital Investment / Paid-up Capital :

INR 0.100 Million

 

 

CIN No.:

[Company Identification No.]

U24230DL2003FTC183289

 

 

IEC No.:

[Import-Export Code No.]

Not Divulged

 

 

GSTIN :

[Goods & Service Tax Registration No.]

07AACCT3536F1ZI

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AACCT3536F

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in Trading of Pharmaceutical Ingredients for Genetic Drugs and rendering business support services. (Registered Activity)

 

 

No. of Employees :

Information denied by the management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Maximum Credit Limit :

USD 1639000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a wholly owned subsidiary of “Teva Pharmaceutical Finance Netherland Bv, and was incorporated in the year 2003. It is having good track records.

 

For the financial year 2017, the company has increased its revenue from operations as compared to previous year and maintained healthy profitability margin of 25.73%.

 

Rating takes into consideration sound financial profile of the company marked by healthy networth base and debt free balance sheet.

 

Further, the company also derives strength from its strong holding company support, established track records of business operations and market positions.

 

Trade relations are reported as fair. Payments are reported to be regular.

 

In view of aforesaid, the company can be considered for normal business dealings at usual trade terms and condition.

 

NOTES : Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 29.03.2018

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Keshav

Designation :

Accounts manager

Contact No.:

91-8326685533

Date :

26.03.2018

 

Name :

Miss Gauri

Designation :

Staff

Contact No.:

91-8326685538

 

Management non-cooperative (Tel No.: 91-9892588136)

 

 

LOCATIONS

 

Registered Office :

M-34 Saket, New Delhi – 110017, India

Tel. No.:

91-120-4073275

Fax No.:

Not Available

E-Mail :

avani.kansara@actavis.com

pramod.ghorpade@actavis.com

Website :

www.tapi.com

http://www.tevapharm.com

 

 

Sales Office :

601, Omega, Hiranandani Garden, Powai, Mumbai - 400076, Maharashtra, India

Tel. No.:

91-22-25705681/ 82

Fax No.:

91-22-25705684

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Mr. Pramod Ramchandra Ghorpade

Designation :

Director

Address :

B/2004, Millennium Avanish, Plot No. 9,10 And 11, Sector 10a, Behind D Mart, A, Navi Mumbai – 400708, Maharashtra, India

Date of Birth/Age :

28.03.1971

Date of Appointment :

14.06.2017

DIN No :

07644110

Other Directorship :

 

CIN/FCRN

Company Name

Begin Date

End Date

U74899DL2002PTC138679

TEVA API INDIA PRIVATE LIMITED

30/09/2016

-

U33111DL2000FTC268478

TEVAPHARM INDIA PRIVATE LIMITED

28/09/2017

-

U24230MH2004PTC148084

ACTAVIS PHARMA PRIVATE LIMITED

27/09/2017

-

U24230MH2005PTC156968

WATSON PHARMA PRIVATE LIMITED

27/09/2017

-

U24239MH2006PTC163981

ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED

27/09/2017

-

U74900DL2016FTC298674

TEVA HEALTHCARE INDIA PRIVATE LIMITED

13/06/2017

-

 

 

Name :

Mr. Raghunathan Ananthanarayanan

Designation :

Director

Address :

Villa No 157, Indu Fortune Fields, 13th Phase, KPHB Colony, Hyderabad 500072, Telangana, India

Date of Appointment :

06.05.2015

DIN No :

02231540

Other Directorship :

 

CIN/FCRN

Company Name

Begin Date

End Date

U74899DL2002PTC138679

TEVA API INDIA PRIVATE LIMITED

30/09/2016

-

 

 

Name :

Mr. Gaurav Mathur

Designation :

Director

Address :

HIG - 101, Sector - E, Aliganj, Lucknow - 226022, Uttar Pradesh, India

Date of Appointment :

30.09.2016

DIN No :

07610237

Other Directorship :

 

CIN/FCRN

Company Name

Begin Date

End Date

U74899DL2002PTC138679

TEVA API INDIA PRIVATE LIMITED

30/09/2016

-

U33111DL2000FTC268478

TEVAPHARM INDIA PRIVATE LIMITED

28/09/2017

-

U24230MH2004PTC148084

ACTAVIS PHARMA PRIVATE LIMITED

27/09/2017

-

U24230MH2005PTC156968

WATSON PHARMA PRIVATE LIMITED

27/09/2017

-

U24239MH2006PTC163981

ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED

27/09/2017

-

 

 

KEY EXECUTIVES

 

Name :

Neha Gupta and Associates

Designation :

Company Secretary

 


 

MAJOR SHAREHOLDERS

 

As on 31.03.2017

 

Names of Shareholders

No. of Shares

% of Holding

Teva pharmaceutical Finance Netherland BV

9999

99.99

Kapil Dev Sapra

1

0.01

Total

10000

100.00

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 28.09.2017

 

Category

Percentage

Promoters (Individual/Hindu Undivided Family – Indian)

0.01

Promoters (Body corporate)

99.99

Total 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in Trading of Pharmaceutical Ingredients for Genetic Drugs and rendering business support services. (Registered Activity)

 

 

Products / Services :

Item Code No.

Products/Services Description

99611730

Pharmaceutical products

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

Information denied by the management

 

 

Bankers :

Banker Name :

Not Divulged

Branch :

Not Divulged

Person Name (With Designation) :

--

Contact Number :

--

Name of Account Holder :

--

Account Number :

--

Account Since (Date/Year of Account Opening) :

--

Average Balance Maintained :

--

Credit Facilities Enjoyed (CC/OD/Term Loan) :

--

Account Operation :

--

Remark :

--

 

 

Auditors :

 

Name :

O. Aggarwal and Company

Chartered Accountants

Address :

H-3/11-A, Krishna Nagar, Delhi-110051, India

Tel. No.:

91-11-22420688/ 22017315

Mobile No.:

91-9891577403

Income-tax PAN of auditor or auditor's firm :

AAAFO6019P

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Fellow Subsidiaries :

  • Teva API India Private Limited
  • Teva API International S. A. Spain
  • Teva Pharmaceutical Works Private Limited
  • Ratiopharma GMBH Germany
  • Assia Chemical Private Limited
  • Lus Chemical S. A
  • Tevapharma India Private Limited
  • Teva India Private Limited
  • Watson Pharma Private Limited

 

 

Holding Company (Where control Exists) :

  • Teva Pharmaceutical Finance Netherlands B. V.
  • Teva Pharmaceutical Industries Limited

 

 

CAPITAL STRUCTURE

 

As on 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

200,000

Equity Shares

INR 10/- each

INR 2.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10,000

Equity Shares

INR 10/- each

INR 0.100 Million

 

 

 

 

 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

0.100

0.100

0.100

(b) Reserves & Surplus

573.781

365.334

275.783

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds

573.881

365.434

275.883

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities

0.000

0.000

0.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

152.719

35.813

32.917

(c) Other current liabilities

29.731

26.625

26.629

(d) Short-term provisions

34.518

3.240

6.075

Total Current Liabilities

216.968

65.678

65.621

 

 

 

 

TOTAL

790.849

431.112

341.504

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

0.823

0.767

2.095

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

1.888

0.035

0.236

(d)  Long-term Loan and Advances

4.528

4.528

4.528

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

7.239

5.330

6.859

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

0.000

0.000

0.000

(c) Trade receivables

430.836

171.073

153.877

(d) Cash and cash equivalents

339.833

250.587

179.483

(e) Short-term loans and advances

0.829

1.238

0.675

(f) Other current assets

12.112

2.884

0.610

Total Current Assets

783.610

425.782

334.645

 

 

 

 

TOTAL

790.849

431.112

341.504

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Income

810.097

360.576

265.531

 

Other Income

17.461

13.621

11.745

 

TOTAL

827.558

374.197

277.276

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Purchases of Stock-in-Trade

425.045

174.985

98.768

 

Employees benefits expense

28.504

21.926

19.564

 

Other expenses

50.098

38.272

33.302

 

TOTAL

503.647

235.183

151.634

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

323.911

139.014

125.642

 

 

 

 

 

Less

FINANCIAL EXPENSES

3.594

0.371

0.665

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

320.317

138.643

124.977

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION

0.501

0.770

1.097

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

319.816

137.873

123.880

 

 

 

 

 

Less

TAX

111.368

48.322

42.230

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

208.448

89.551

81.650

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

20.845

8.955

8165

 

 

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

163.849

110.218

38.305

Net cash flows from (used in) operating activity

74.367

57.359

(2.480)

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

194.12

173.17

211.52

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

1.88

2.11

1.73

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

131.14

74.70

121.65

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.00

0.00

0.00

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

393.57

181.24

59.97

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.27

0.15

0.19

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.00

0.00

0.00

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.38

0.18

0.24

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.00

0.00

0.01

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

90.13

374.70

188.94

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

25.73

24.84

30.75

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

26.36

20.77

23.91

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

36.32

24.51

29.60

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

3.61

6.48

5.10

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

3.61

6.48

5.10

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.73

0.85

0.81

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

0.00

0.00

0.00

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

3.61

6.48

5.10

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

(INR in Million)

(INR in Million)

(INR in Million)

Share Capital

0.100

0.100

0.100

Reserves & Surplus

275.783

365.334

573.781

Money received against share warrants

0.000

0.000

0.000

 Share Application money pending allotment

0.000

0.000

0.000

Net worth

275.883

365.434

573.881

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

(INR in Million)

(INR in Million)

(INR in Million)

Sales

265.531

360.576

810.097

 

 

35.794

124.667

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

(INR in Million)

(INR in Million)

(INR in Million)

Sales

265.531

360.576

810.097

Profit

81.650

89.551

208.448

 

30.75%

24.84%

25.73%

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of establishment

Yes

2]

Constitution of the entity Incorporation details

Yes

3]

Locality of the entity

Yes

4]

Premises details

Yes

5]

Buyer visit details

--

6]

Contact numbers

Yes

7]

Name of the person contacted

Yes

8]

Designation of contact person

Yes

9]

Promoter’s background

Yes

10]

Date of Birth of Proprietor / Partners / Directors

Yes

11]

Pan Card No. of Proprietor / Partners

No

12]

Voter Id Card No. of Proprietor / Partners

No

13]

Type of business

Yes

14]

Line of Business

Yes

15]

Export/import details (if applicable)

No

16]

No. of employees

No

17]

Details of sister concerns

Yes

18]

Major suppliers

No

19]

Major customers

No

20]

Banking Details

No

21]

Banking facility details

No

22]

Conduct of the banking account

--

23]

Financials, if provided

Yes

24]

Capital in the business

Yes

25]

Last accounts filed at ROC, if applicable

Yes

26]

Turnover of firm for last three years

Yes

27]

Reasons for variation <> 20%

--

28]

Estimation for coming financial year

No

29]

Profitability for last three years

Yes

30]

Major shareholders, if available

Yes

31]

External Agency Rating, if available

No

32]

Litigations that the firm/promoter involved in

--

33]

Market information

--

34]

Payments terms

No

35]

Negative Reporting by Auditors in the Annual Report

No

 

 

INDEX OF CHARGES No Charges Exists for Company

 

 

 

 

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 64.80

UK Pound

1

INR 92.26

Euro

1

INR 80.76

 

 

INFORMATION DETAILS

 

Information Gathered by :

SHR

 

 

Analysis Done by :

PSD

 

 

Report Prepared by :

TRUP

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.